Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mehta

Showing results (801-810 of 1,815) with videos related to

Pageof 182
Sort By:
Maternal and Child Health Journal|June 1, 2024
Clinical and Demographic Characteristics of Patient-Initiated Encounters Before the 6-Week Postpartum VisitDanielle L Falde, Lillian J Dyre, Ramila A Mehta, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemiaParinda A Mehta, Richard E Harris, Stella M Davies, et al.
Circulation|June 1, 1981
His-Purkinje responses and refractory periods during atrial extrastimulation in children with heart defectsG S Wolff, A Mehta, D Tamer, et al.
Annals of Vascular Surgery|September 19, 2009
Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudicationF A K Mazari, S Gulati, M N A Rahman, et al.
Pediatric Blood & Cancer|February 2, 2012
Endocrine phenotype of children and adults with Fanconi anemiaSusan R Rose, Kasiani C Myers, Meilan M Rutter, et al.
Pediatric Blood & Cancer|April 13, 2006
Chemotherapy for myeloid malignancy in children with Fanconi anemiaParinda A Mehta, Talia Ileri, Richard E Harris, et al.
Parkinsonism & Related Disorders|March 3, 2019
The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's diseaseHeather Wilson, Gennaro Pagano, Flavia Niccolini, et al.
Lancet (London, England)|December 5, 2009
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry dataA Mehta, M Beck, P Elliott, et al.
European Journal of Clinical Investigation|March 18, 2004
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome SurveyA Mehta, R Ricci, U Widmer, et al.
The Journal of Antimicrobial Chemotherapy|February 27, 2018
Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic studySharat Chandra, Tsuyoshi Fukuda, Kana Mizuno, et al.
Pageof 182

Showing results (801-810 of 1,815) with videos related to

Sort By:
Pageof 182
Maternal and Child Health Journal|June 1, 2024
Clinical and Demographic Characteristics of Patient-Initiated Encounters Before the 6-Week Postpartum VisitDanielle L Falde, Lillian J Dyre, Ramila A Mehta, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemiaParinda A Mehta, Richard E Harris, Stella M Davies, et al.
Circulation|June 1, 1981
His-Purkinje responses and refractory periods during atrial extrastimulation in children with heart defectsG S Wolff, A Mehta, D Tamer, et al.
Annals of Vascular Surgery|September 19, 2009
Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudicationF A K Mazari, S Gulati, M N A Rahman, et al.
Pediatric Blood & Cancer|February 2, 2012
Endocrine phenotype of children and adults with Fanconi anemiaSusan R Rose, Kasiani C Myers, Meilan M Rutter, et al.
Pediatric Blood & Cancer|April 13, 2006
Chemotherapy for myeloid malignancy in children with Fanconi anemiaParinda A Mehta, Talia Ileri, Richard E Harris, et al.
Parkinsonism & Related Disorders|March 3, 2019
The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's diseaseHeather Wilson, Gennaro Pagano, Flavia Niccolini, et al.
Lancet (London, England)|December 5, 2009
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry dataA Mehta, M Beck, P Elliott, et al.
European Journal of Clinical Investigation|March 18, 2004
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome SurveyA Mehta, R Ricci, U Widmer, et al.
The Journal of Antimicrobial Chemotherapy|February 27, 2018
Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic studySharat Chandra, Tsuyoshi Fukuda, Kana Mizuno, et al.
Pageof 182